Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesActive in the last 2 years

Lili Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6568-0404; OpenAlex author ID A5019260570. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell-engineered mesothelin-redirected CAR-NKT cells. Last author DOI 10.1073/pnas.2517786122↗
  2. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go? Co-author DOI 10.3389/fonc.2022.828223↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan-Ruide Li · 1 shared paper, 2025 · strength 0.26
  2. Caius Gabriel Radu · 1 shared paper, 2025 · strength 0.26
  3. Dan Chen · 1 shared paper, 2022 · strength 0.13
  4. Chenqi Wang · 1 shared paper, 2022 · strength 0.13
  5. Yunlong Chen · 1 shared paper, 2022 · strength 0.13
  6. Xiang 'Anthony' Chen · 1 shared paper, 2022 · strength 0.13
  7. Guang Tan · 1 shared paper, 2022 · strength 0.13
  8. Jiangning Gu · 1 shared paper, 2022 · strength 0.13
  9. Haifeng Luo · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.